0000890821
EX-FILING FEES
0000890821
2026-02-09
2026-02-09
0000890821
1
2026-02-09
2026-02-09
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
xbrli:pure
Exhibit 107
Calculation of Filing Fee Tables
Form S-1
(Form Type)
Enveric Biosciences, Inc.
(Exact Name of Each Registrant
as Specified in its Charter)
Table 1: Newly Registered and Carry Forward
Securities
Security
Type | |
Security
Class Title | |
Fee
Calculation or Carry Forward Rule | |
Amount
Registered (1) | | |
Proposed
Maximum Offering Price Per Unit | | |
Maximum
Aggregate Offering Price | | |
Fee
Rate | | |
Amount
of Registration Fee | |
| Equity | |
Common Stock, par value $0.01 per share ("Common Stock"),underlying warrants to purchase Common Stock | |
Other | |
| 680,620 | | |
| $2.70 | (2) | |
$ | 1,837,674.00 | | |
| 0.00013810 | | |
$ | 253.78 | |
| Total Offering Amounts | | |
| | | |
$ | 1,837,674.00 | | |
| | | |
$ | 253.78 | |
| Total Fees Previously Paid | | |
| | | |
| | | |
| | | |
| - | |
| Total Fee Offsets | | |
| | | |
| | | |
| | | |
| - | |
| Net Fee Due | | |
| | | |
| | | |
| | | |
$ | 253.78 | |
| (1) |
Pursuant to Rule 416(a) under the Securities Act of 1933, as amended (the “Securities Act”), the number of shares registered hereunder includes such additional number of shares of common stock, par value $0.01 per share (the “Common Stock”) of Enveric Biosciences, Inc. (the “Company”), as are required to prevent dilution resulting from a stock split, stock dividend or similar transaction. |
| |
|
| (2) |
The offering price has been estimated solely for the purposes of the calculation of the registration fee. The offering price has been calculated in accordance with the manner described in paragraphs (c) and (h) of Rule 457 under the Securities Act and is based upon the average of high and low prices reported by the Nasdaq Capital Market on February 5, 2026, a date within five (5) business days prior to the date of the filing of this Registration Statement. |
N/A